161 related articles for article (PubMed ID: 32332303)
1. Pearls and Pitfalls in Interpretation of 68Ga-DOTATOC PET Imaging.
Bashir A; Broholm H; Clasen-Linde E; Vestergaard MB; Law I
Clin Nucl Med; 2020 Jun; 45(6):e279-e280. PubMed ID: 32332303
[TBL] [Abstract][Full Text] [Related]
2. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of [
Bashir A; Vestergaard MB; Binderup T; Broholm H; Marner L; Ziebell M; Fugleholm K; Mathiesen T; Kjær A; Law I
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2577-2588. PubMed ID: 32170347
[TBL] [Abstract][Full Text] [Related]
4. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
[TBL] [Abstract][Full Text] [Related]
5. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.
Miederer M; Seidl S; Buck A; Scheidhauer K; Wester HJ; Schwaiger M; Perren A
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):48-52. PubMed ID: 18807033
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A
Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
Afshar-Oromieh A; Wolf MB; Kratochwil C; Giesel FL; Combs SE; Dimitrakopoulou-Strauss A; Gnirs R; Roethke MC; Schlemmer HP; Haberkorn U
Neuro Oncol; 2015 Feb; 17(2):312-9. PubMed ID: 25008094
[TBL] [Abstract][Full Text] [Related]
10. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
Rachinger W; Stoecklein VM; Terpolilli NA; Haug AR; Ertl L; Pöschl J; Schüller U; Schichor C; Thon N; Tonn JC
J Nucl Med; 2015 Mar; 56(3):347-53. PubMed ID: 25635133
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications.
Roytman M; Pisapia DJ; Liechty B; Lin E; Skafida M; Magge RS; Osborne JR; Pannullo SC; Knisely JPS; Ramakrishna R; Ivanidze J
Clin Imaging; 2020 Oct; 66():18-22. PubMed ID: 32442855
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases.
Unterrainer M; Ruf V; Ilhan H; Vettermann FJ; Cyran CC; Niyazi M; Bartenstein P; Tonn JC; Albert NL
Clin Nucl Med; 2019 May; 44(5):412-413. PubMed ID: 30829858
[TBL] [Abstract][Full Text] [Related]
13. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
[TBL] [Abstract][Full Text] [Related]
14. Influence of
Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
[TBL] [Abstract][Full Text] [Related]
15. Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.
Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
J Neurooncol; 2013 Jul; 113(3):519-26. PubMed ID: 23657621
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Provost C; Prignon A; Cazes A; Combaret V; Delattre O; Janoueix-Lerosey I; Montravers F; Talbot JN
Anticancer Res; 2016 Sep; 36(9):4459-66. PubMed ID: 27630282
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Metastasis Mimicking Meningioma in 68Ga-DOTATOC PET/CT.
Fabritius MP; Geyer T; Ahmaddy F; Albert NL; Bartenstein P; Tiling R; Rübenthaler J; Holzgreve A
Clin Nucl Med; 2021 Nov; 46(11):922-923. PubMed ID: 34132678
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-DOTATOC-PET/CT-guided resection of a primary intraosseous meningioma: technical note.
Guinto-Nishimura GY; Gómez-Amador JL; Kerik-Rotenberg N; Uribe-Pacheco R; Sangrador-Deitos MV; Martínez-Manrique JJ
Neurosurg Focus; 2021 Jan; 50(1):E6. PubMed ID: 33386007
[TBL] [Abstract][Full Text] [Related]
19. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
Iglseder S; Iglseder A; Beliveau V; Heugenhauser J; Gizewski ER; Kerschbaumer J; Stockhammer G; Uprimny C; Virgolini I; Dudas J; Nevinny-Stickel M; Nowosielski M; Scherfler C
J Neurooncol; 2023 Sep; 164(3):711-720. PubMed ID: 37707754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
